Hepatitis C DNA vaccine - Merck & Co.
Alternative Names: HCV DNA vaccine - Merck & Co.Latest Information Update: 14 Sep 2022
At a glance
- Originator Merck & Co
- Class Antivirals; DNA vaccines; Hepatitis C vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 07 Sep 2022 Brickell Biotech Inc is now called Fresh Tracks Therapeutics
- 31 Aug 2019 Brickell Biotech has merged with Vical to form Brickell Biotech Inc, and subsequently Brickell Biotech changed its name to Brickell Subsidiary
- 04 Nov 2017 No recent reports of development identified for research development in Hepatitis-C in USA (IM)